Could a weight loss shot lower breast cancer risk?
NCT ID NCT06485089
Summary
This study is checking if the weight loss medication tirzepatide changes markers in the body that are linked to breast cancer risk. It involves 20 women with obesity who are already planning to take tirzepatide. Researchers will measure things in their blood, breast tissue, and scans before and after several months of treatment to see if risk factors improve.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
-
University of Kansas Medical Center Breast Cancer Prevention Center
Westwood, Kansas, 66208, United States
Conditions
Explore the condition pages connected to this study.